Corneal Neovascularization Clinical Trials

25 clinical trials for Corneal Neovascularization across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• UV Light-mediated Corneal Crosslinking as (Lymph)Angioregressive Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision] — RECRUITING
• Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization. — RECRUITING · PHASE1
• Corneal Crosslinking for Treatment of Corneal Neovascularization — RECRUITING · PHASE2
• Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization — COMPLETED · PHASE2
• Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies — OTHER
• Correlation Between a Novel Subset of Neutrophil and Corneal Neovascularization. — OTHER
• Topical Avastin for Treatment of Corneal Neovascularization — COMPLETED · PHASE1
• The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization — OTHER · PHASE1
• Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment — OTHER · PHASE1
• A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival — COMPLETED · PHASE1
• An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization — OTHER · PHASE1
• Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization — TERMINATED · PHASE1
• Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival — COMPLETED · PHASE1
• Treatment of Corneal Neovascularization With Topical Pazopanib — COMPLETED · PHASE1
• Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery — COMPLETED · PHASE1
• Topical IL-1-Ra for Treatment of Corneal Neovascularization — TERMINATED · PHASE1
• Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions — WITHDRAWN · PHASE1
• Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea — TERMINATED · PHASE1
• Corneal Thinning During Topical Bevacizumab Therapy — WITHDRAWN · NA
• Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization — COMPLETED · NA
• Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization — COMPLETED · NA
• Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) — COMPLETED · PHASE1
• The Effect of Bevacizumab on Corneal Neovascularization — COMPLETED · PHASE4
• Bevacizumab for the Treatment of Corneal Neovascularization — OTHER · PHASE2
• Photodynamic Therapy With Verteporfin for Corneal Neovascularization — COMPLETED · NA

Refine this search